Hormone Therapy in the Era of the COVID-19 Pandemic: A Review

Area of Science:

• Reproductive Health
• Endocrinology
• Infectious Diseases

Background:

• The COVID-19 pandemic has significantly affected global health, including reproductive health.
• COVID-19's systemic impact necessitates careful consideration in patient management, particularly for vulnerable populations like those over 50.
• Existing evidence on hormone therapy in gynecology during the pandemic is limited.

Purpose of the Study:

• To analyze and summarize current research on female hormone therapy in the context of the COVID-19 pandemic.
• To provide a reference for clinical application of hormone therapy in gynecology during the pandemic.
• To address the gap in high-quality evidence for individualized patient management.

Main Methods:

• Systematic review of existing studies on COVID-19 and female hormone therapy.
• Analysis of clinical data and research findings related to gynecological care during the pandemic.
• Synthesis of evidence to assess the benefits and risks of hormone therapy.

Main Results:

• The pandemic has raised concerns about hormone therapy's safety and efficacy.
• Evidence for specific recommendations on hormone therapy in gynecology remains insufficient.
• Older women with COVID-19 require special attention regarding hormone therapy.

Conclusions:

• Further high-quality research is needed to establish evidence-based guidelines for female hormone therapy during the COVID-19 pandemic.
• Individualized management strategies are crucial for gynecological patients on hormone therapy.
• This review serves as a foundational resource for clinicians navigating this complex area.